Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,146 | -234,509 | -56,868 | 27,337 | -7,311 |
| Depreciation Amortization | 24,268 | 35,712 | 33,331 | 17,128 | 12,633 |
| Accounts receivable | 3,131 | 35,816 | -22,111 | 9,476 | -33,247 |
| Accounts payable and accrued liabilities | N/A | -22,546 | 20,977 | -903 | 6,958 |
| Other Working Capital | -37,206 | 21,715 | 6,100 | -17,751 | -15,606 |
| Other Operating Activity | 6,127 | 128,339 | 2,967 | -283 | 40,573 |
| Operating Cash Flow | $-54,826 | $-35,472 | $-15,604 | $35,003 | $4,001 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 3,240 |
| PPE Investments | -8,111 | -1,794 | 54,058 | -13,010 | -17,152 |
| Net Acquisitions | 9,743 | N/A | -122,708 | N/A | N/A |
| Other Investing Activity | 4,463 | 5,284 | -1,187 | 0 | 44 |
| Investing Cash Flow | $6,094 | $3,490 | $-69,838 | $-13,010 | $-13,869 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 80,233 | N/A | N/A |
| Debt Repayment | -504 | N/A | -38,868 | N/A | N/A |
| Common Stock Issued | 18,965 | 810 | 99,143 | 70,955 | 52,721 |
| Other Financing Activity | -15,314 | -16,611 | -18,521 | -7,416 | -3,692 |
| Financing Cash Flow | $3,147 | $-15,801 | $121,986 | $63,539 | $49,030 |
| Exchange Rate Effect | -1,017 | 1,051 | 3,458 | N/A | N/A |
| Beginning Cash Position | 112,231 | 175,744 | 134,753 | 64,276 | 20,856 |
| End Cash Position | 65,629 | 129,012 | 174,755 | 149,809 | 60,018 |
| Net Cash Flow | $-46,602 | $-46,732 | $40,003 | $85,533 | $39,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,826 | -35,472 | -15,604 | 35,003 | 4,001 |
| Capital Expenditure | -8,111 | -12,230 | -20,157 | -13,010 | -17,152 |
| Free Cash Flow | -62,937 | -47,702 | -35,760 | 21,993 | -13,151 |